Daniel Ives
CEO & Founder, Shift Bioscience
Daniel received his PhD from the University of Cambridge in 2013, using computational biology to identify a therapeutic approach for an intractable mitochondrial disease. In 2017 he founded Shift Bioscience with a mission to reverse human aging, building an AI x Bio team whose goal is to translate a drug capable of prolonging both healthspan and lifespan.